Rx Medicare

Less than a month after launching the largest flu prevention initiative in the company’s 108-year history, Walgreens (NYSE: WAG)(NASDAQ: WAG) is taking proactive measures to ensure its nearly 7,000 pharmacies can provide the suspension – or liquid – form of seasonal flu-fighting drug Tamiflu this season.

Read More…

Related Posts

• Publix Pharmacies To Compound Tamiflu Into Oral Suspension
• Vaccinating Children For Flu May Help Prevent Transmission, Protect Those Who Are Not Vaccinated
• Pandemic Flu, Like Seasonal H1N1, Shows Signs Of Resisting Tamiflu
• Flu-Induced Stress Response Is Critical For Resistance To Secondary Infection
• Amarillo Biosciences Announces Australian Phase 2 Oral Interferon Clinical Trial Indicates Benefit In Preventing Influenza-Like Illness In Seniors
• SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN’s Ability To Enhance Response To H1N1 Vaccine
• A(H1N1) Influenza Pandemic: Sanofi Pasteur’s Global Response
• Welsh Assembly Government Encourages Parents To Have Children Under Five Vaccinated Against Swine Flu, Wales
• Toward A Less Expensive Version Of The Anti-flu Drug Tamiflu
• Drive-Through Emergency Service Effective Response To Pandemic, Stanford Study Shows
• SciClone And Sigma-Tau Announce Positive Preliminary Results In Clinical Study Examining ZADAXIN’S Ability To Enhance Response To H1N1 Vaccine
• H1N1 Health Alert: Children With Asthma At Greater Risk From H1N1 Influenza
• Update On Person To Person Spread Of Swine Flu Resistant To Tamiflu, Wales
• An Overactive Immune Response Linked To Viral Infections Among Elderly
• FDA Expands Use Of CSL Limited’s Seasonal And H1N1 Vaccines To Infants And Children

Tags: children, compound, efficacy, oral, response, shortage, supply, suspension, tamiflu, walgreens

This entry was posted on Monday, September 28th, 2009 at 3:09 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.